<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60039</article-id><article-id pub-id-type="doi">10.17816/dv60039</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ ДЕРМАТОЗОВ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Microbiome and acne vulgaris</article-title><trans-title-group xml:lang="ru"><trans-title>Микробиом и вульгарные угри</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ma</surname><given-names>Ziyuan</given-names></name><name xml:lang="ru"><surname>Ма</surname><given-names>Цзыюань</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Post-graduate student of the Department of Skin and Venereal Diseases named after V.A. Rakhmanov, Institute of Clinical Medicine named after N.V. Sklifosovsky</p></bio><bio xml:lang="ru"><p>аспирант кафедры кожных и венерических болезней им В.А.Рахманова Института клинической медицины им Н.В.Склифосовского</p></bio><email>stephanie92@foxmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7136-4053</contrib-id><contrib-id contrib-id-type="scopus">6602082412</contrib-id><name-alternatives><name xml:lang="en"><surname>Kochergin</surname><given-names>Nikolay G.</given-names></name><name xml:lang="ru"><surname>Кочергин</surname><given-names>Николай Георгиевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>dr. medical sciences, prof. Department of Skin and Venereal Diseases named after V.A. Rakhmanov Institute of Clinical Medicine named after V.A. N.V. Sklifosovsky</p></bio><bio xml:lang="ru"><p>д-р. мед наук, проф. кафедры кожных и венерических болезней им. В.А.Рахманова Института клинической медицины им. Н.В.Склифосовского</p></bio><email>nkocha@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>23</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>388</fpage><lpage>394</lpage><history><date date-type="received" iso-8601-date="2021-02-04"><day>04</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-03-22"><day>22</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Эко-Вектор"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-08-01"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/60039">https://rjsvd.com/1560-9588/article/view/60039</self-uri><abstract xml:lang="en"><p><italic>Acne vulgaris is a highly prevalent inflammatory skin disease involving sebaceous follicle. Although the pathogensis of acne remains uncertain, skin microbes are considered to plays an essential role in acne vulgaris. Cutibacterium acnes is the most important microbe in acne pathogenesis and its several processes: colonization, over-proliferation and inflammation have long been thought to contribute to the disease. Moreover, Staphylococcus epidermidis and Malassezia also synergistically collaborate with Cutibacterium acnes. Besides, given the growing number of patients who are treatment resistant, assessments are needed on phenotypic changes in the skin microbiome with retinoids and antibacterial therapy. Further research on the role of microbes in the pathogenesis of acne and the relationship between pathogenic microbes is expected to provide a new theoretical basis for clinical treatment of acne.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic>Вульгарные угри – широко распространённое воспалительное заболевание кожи с участием сальных фолликулов. Хотя патогенез акне до конца не изучен, считается, что кожные микробы Cutibacterium acnes играют важную роль в развитии вульгарных угрей. Колонизация C. acnes, их чрезмерное размножение с последующим воспалением, как давно признано, способствуют развитию болезни. Более того, Staphylococcus epidermidis и Malassezia также синергетически взаимодействуют с C. acnes. Таким образом, с учётом растущего числа пациентов, устойчивых к лечению, необходима оценка фенотипических изменений микробиома кожи под воздействием ретиноидов и антибактериальной терапии. Ожидается, что дальнейшее исследование роли микробов в патогенезе угрей и взаимосвязи между патогенными микробами обеспечит новую теоретическую основу для терапевтических подходов к акне.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>acne vulgaris</kwd><kwd>microbiome</kwd><kwd>antibactiral therapies</kwd><kwd>retinoids</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вульгарные угри</kwd><kwd>микробиом</kwd><kwd>антибактериальная терапия</kwd><kwd>ретиноиды</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Monakhov SA, Ivanov OL. Acne: Handbook for Physicians. Moscow; 2010. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Монахов С.А., Иванов О.Л. Акне. Методическое пособие для врачей. М.; 2010.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3-12.</mixed-citation><mixed-citation xml:lang="ru">Tan J.K., Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3-12.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Nelyubova OI, Talnikova EE, Morrison AV. The skin microbiome and its role in health and disease. Russian Journal of Skin and Venereal Diseases. 2016;19(2):97. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Нелюбова О.И., Тальникова Е.Е., Моррисон А.В. Микробиом кожи и его роль в норме и патологии // Российский журнал кожных и венерических болезней. 2016;19(2):97.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Araviyskaya ER, Sokolovsky EV. The microbiome: a new era in the study of healthy and diseased skin // Vestnik Dermatologii i Venerologii. 2016;(3):102-9. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Аравийская Е.Р., Соколовский Е.В. Микробиом: новая эра в изучении здоровой и патологически измененной кожи // Вестник дерматологии и венерологии 2016;(3):102-9.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Gilchrist TC. A bacteriological and microscopical study of over 300 vesicular and pustular lesions of the skin, with a research upon the etiology of acne vulgaris. Johns Hopkins Hospital Report. 1900;(9):409-30.</mixed-citation><mixed-citation xml:lang="ru">Gilchrist T.C. A bacteriological and microscopical study of over 300 vesicular and pustular lesions of the skin, with a research upon the etiology of acne vulgaris». Johns Hopkins Hospital Report. 1900;(9):409-30.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Douglas HC, Gunter SE. The taxonomic position of Corynebacterium acnes. J Bacteriol. 1946;52(1):15-23.</mixed-citation><mixed-citation xml:lang="ru">Douglas H.C., Gunter S.E. The taxonomic position of Corynebacterium acnes. J Bacteriol. 1946;52(1):15-23.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Scholz CF, Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66(11):4422-32.</mixed-citation><mixed-citation xml:lang="ru">Scholz C.F., Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66(11):4422-32.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133(9):2152-60.</mixed-citation><mixed-citation xml:lang="ru">Fitz-Gibbon S., Tomida S., Chiu B.H., Nguyen L., Du C., Liu M., et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133(9):2152-60.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Suskova VS, Pinson IYa, Olisova OYu. Immunopathological mechanisms of psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2006;4(1):68-70. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Сускова В.С., Пинсон И.Я., Олисова О.Ю. Иммунопатогенез псориаза // Клиническая дерматология и венерология. 2006;4(1):68-70.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol. 2004;150(3):421-8.</mixed-citation><mixed-citation xml:lang="ru">Graham G.M., Farrar M.D., Cruse-Sawyer J.E., Holland K.T., Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol. 2004;150(3):421-8.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B. Induction of Toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105-13.</mixed-citation><mixed-citation xml:lang="ru">Jugeau S., Tenaud I., Knol A.C., Jarrousse V., Quereux G., Khammari A., Dreno B. Induction of Toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105-13.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Mouser PE, Baker BS, Seaton ED, Chu AC. Propionibacterium acnes-reactive Th1 cells in the skin of patients with acne vulgaris. J Invest Dermatol. 2003;121(5):1226-8.</mixed-citation><mixed-citation xml:lang="ru">Mouser P.E., Baker B.S., Seaton E.D., Chu A.C. Propionibacterium acnes-reactive Th1 cells in the skin of patients with acne vulgaris. J Invest Dermatol. 2003;121(5):1226-8.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110-8.</mixed-citation><mixed-citation xml:lang="ru">Kistowska M., Meier B., Proust T., Feldmeyer L., Cozzio A., Kuendig T., et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110-8.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Isard O, Knol AC, Aries MF, Nguyen JM, Khammari A, CastexRizzi N, Dreno B. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. J Invest Dermatol. 2011;131(1):59-66.</mixed-citation><mixed-citation xml:lang="ru">Isard O., Knol A.C., Aries M.F., Nguyen J.M., Khammari A., Castex-Rizzi N., Dreno B. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation. J Invest Dermatol. 2011;131(1):59-66.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Huang YC, Yang CH, Li TT, Zouboulis CC, Hsu HC. Cell-free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll-like receptor in SZ95 sebocytes. Life Sci. 2015;139:123-31.</mixed-citation><mixed-citation xml:lang="ru">Huang Y.C., Yang C.H., Li T.T., Zouboulis C.C., Hsu H.C. Cell-free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll-like receptor in SZ95 sebocytes. Life Sci. 2015;139:123-31.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527-32.</mixed-citation><mixed-citation xml:lang="ru">Zouboulis C.C., Jourdan E., Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28(5):527-32.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28(3):271-8.</mixed-citation><mixed-citation xml:lang="ru">Beylot C., Auffret N., Poli F., Claudel J.P., Leccia M.T., Del Giudice P., Dreno B. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28(3):271-8.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">McDowell A, Barnard E, Liu J, Li H, Patrick S. Corrigendum: Proposal to reclassify Propionibacterium acnes type I as Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov. Int J Syst Evol Microbiol. 2017;67(11):4880.</mixed-citation><mixed-citation xml:lang="ru">McDowell A., Barnard E., Liu J., Li H., Patrick S. Corrigendum: Proposal to reclassify Propionibacterium acnes type I as Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov. Int J Syst Evol Microbiol. 2017;67(11):4880.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Dekio I, McDowell A, Sakamoto M, Tomida S, Ohkuma M. Proposal of new combination, Cutibacterium acnes subsp. elongatum comb. nov., and emended descriptions of the genus Cutibacterium, Cutibacterium acnes subsp. acnes and Cutibacterium acnes subsp. defendens. Int J Syst Evol Microbiol. 2019;69(4):1087-92.</mixed-citation><mixed-citation xml:lang="ru">Dekio I., McDowell A., Sakamoto M., Tomida S., Ohkuma M. Proposal of new combination, Cutibacterium acnes subsp. elongatum comb. nov., and emended descriptions of the genus Cutibacterium, Cutibacterium acnes subsp. acnes and Cutibacterium acnes subsp. defendens. Int J Syst Evol Microbiol. 2019;69(4):1087-92.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Dekio I, Culak R, Misra R, Gaulton T, Fang M, Sakamoto M, et al. Dissecting the taxonomic heterogeneity within Propionibacterium acnes: Proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. Int J Syst Evol Microbiol. 2015;65(12):4776-87.</mixed-citation><mixed-citation xml:lang="ru">Dekio I., Culak R., Misra R., Gaulton T., Fang M., Sakamoto M., et al. Dissecting the taxonomic heterogeneity within Propionibacterium acnes: Proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov. Int J Syst Evol Microbiol. 2015;65(12):4776-87.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">McDowell A, Barnard E, Nagy I, Gao A, Tomida S, Li H, et al. An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of ‘pathogenic’, ‘commensal’ and antibiotic resistant strains. PLoS One. 2012;7(7):e41480.</mixed-citation><mixed-citation xml:lang="ru">McDowell A., Barnard E., Nagy I., Gao A., Tomida S., Li H., et al. An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of ‘pathogenic’, ‘commensal’ and antibiotic resistant strains. PLoS One. 2012;7(7):e41480.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Kwon HH, Yoon JY, Park SY, Suh DH. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions. Br J Dermatol. 2013;169(5):1152-5.</mixed-citation><mixed-citation xml:lang="ru">Kwon H.H., Yoon J.Y., Park S.Y., Suh D.H. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions. Br J Dermatol. 2013;169(5):1152-5.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Holland KT, Cunliffe WJ, Eady EA. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. J Med Microbiol. 1979;12(1):71-82.</mixed-citation><mixed-citation xml:lang="ru">Holland K.T., Cunliffe W.J., Eady E.A. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. J Med Microbiol. 1979;12(1):71-82.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Mertz D, Frei R, Periat N, Zimmerli M, Battegay M, Fluckiger U, Widmer AF. Exclusive Staphylococcus aureus throat carriage: At-risk populations. Arch Intern Med. 2009;169(2):172-8.</mixed-citation><mixed-citation xml:lang="ru">Mertz D., Frei R., Periat N., Zimmerli M., Battegay M., Fluckiger U., Widmer A.F. Exclusive Staphylococcus aureus throat carriage: At-risk populations. Arch Intern Med. 2009;169(2):172-8.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol. 2011;147(8):917-21.</mixed-citation><mixed-citation xml:lang="ru">Fanelli M., Kupperman E., Lautenbach E., Edelstein P.H., Margolis D.J. Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol. 2011;147(8):917-21.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Khorvash F, Abdi F, Kashani HH, Naeini FF, Narimani T. Staphylococcus aureus in Acne Pathogenesis: A Case-Control Study. N Am J Med Sci. 2012;4(11):573-6.</mixed-citation><mixed-citation xml:lang="ru">Khorvash F., Abdi F., Kashani H.H., Naeini F.F., Narimani T. Staphylococcus aureus in Acne Pathogenesis: A Case-Control Study. N Am J Med Sci. 2012;4(11):573-6.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Fey PD, Olson ME. Current concepts in biofilm formation of Staphylococcus epidermidis.Future Microbiol. 2010;5(6):917-33.</mixed-citation><mixed-citation xml:lang="ru">Fey P.D., Olson M.E. Current concepts in biofilm formation of. Future Microbiol. 2010;5(6):917-33.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Pathak R, Kasama N, Kumar R, Gautam H. Staphylococcus epidermidis in human skin microbiome associated with acne: A cause of disease or defence? Res J Biotechnol. 2013;8(12):78-82.</mixed-citation><mixed-citation xml:lang="ru">Pathak R., Kasama N., Kumar R., Gautam H. Staphylococcus epidermidis in human skin microbiome associated with acne: A cause of disease or defence? Res J Biotechnol. 2013;8(12):78-82.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><mixed-citation>Otto M. Staphylococcus epidermidis – the ‘accidental’ pathogen. Nat Rev Microbiol. 2009;7(8):555-67.</mixed-citation></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Stevens NT, Sadovskaya I, Jabbouri S, Sattar T, O’Gara JP, Humphreys H, Greene CM. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cell Microbiol. 2009;11(3):421-32.</mixed-citation><mixed-citation xml:lang="ru">Stevens N.T., Sadovskaya I., Jabbouri S., Sattar T., O’Gara J.P., Humphreys H., Greene C.M. Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2. Cell Microbiol. 2009;11(3):421-32.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Christensen GJ, Scholz CF, Enghild J, Rohde H, Kilian M, Thurmer A, et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genomics. 2016;17:152.</mixed-citation><mixed-citation xml:lang="ru">Christensen G.J., Scholz C.F., Enghild J., Rohde H., Kilian M., Thurmer A., et al. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. BMC Genomics. 2016;17:152.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130(9):2211-21.</mixed-citation><mixed-citation xml:lang="ru">Lai Y., Cogen A.L., Radek K.A., Park H.J., Macleod D.T., Leichtle A., et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol. 2010;130(9):2211-21.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Xia X, Li Z, Liu K, Wu Y, Jiang D, Lai Y. Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes – mediated inflammatory response in skin. J Invest Dermatol. 2016;136(3):621-30.</mixed-citation><mixed-citation xml:lang="ru">Xia X., Li Z., Liu K., Wu Y., Jiang D., Lai Y. Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes – mediated inflammatory response in skin. J Invest Dermatol. 2016;136(3):621-30.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Polesko IV, Osipov GA, Kabaeva TI. Microecology of the human body with seborrhea, atopic dermatitis and acne. Children’s Infections. Russian Journal. 2006;5(3):26-33. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Полеско И.В., Осипов Г.А., Кабаева Т.И. Микроэкология организма человека при себорее, атопическом дерматите и акне. Детские инфекции. 2006;5(3):26-33.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Kang SH, Kim HU. The isolation of Malassezia yeasts in the comedones of acne vulgaris. Korean J Med Mycol. 1999;4:33-9. doi: 10.5021/ad.2009.21.1.18.</mixed-citation><mixed-citation xml:lang="ru">Kang S.H., Kim H.U. The isolation of Malassezia yeasts in the comedones of acne vulgaris. Korean J Med Mycol. 1999;4:33-9. doi: 10.5021/ad.2009.21.1.18.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Numata S, Akamatsu H, Akaza N, Yagami A, Nakata S, Matsunaga K. Analysis of facial skin-resident microbiota in Japanese acne patients. Dermatology. 2014;228(1):86-92.</mixed-citation><mixed-citation xml:lang="ru">Numata S., Akamatsu H., Akaza N., Yagami A., Nakata S., Matsunaga K. Analysis of facial skin-resident microbiota in Japanese acne patients. Dermatology. 2014;228(1):86-92.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Coelho MA, Sampaio JP, Gonсalves P. Living and thriving on the skin: Malassezia genomes tell the story. mBio. 2013;4(2):e00117-13.</mixed-citation><mixed-citation xml:lang="ru">Coelho M.A., Sampaio J.P., Gon?alves P. Living and thriving on the skin: Malassezia genomes tell the story. mBio. 2013;4(2):e00117-13.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Akaza N, Akamatsu H, Takeoka S, Mizutani H, Nakata S, Matsunaga K. Increased hydrophobicity in Malassezia species correlates with increased proinflammatory cytokine expression in human keratinocytes. Med Mycol. 2012;50(8):802-10.</mixed-citation><mixed-citation xml:lang="ru">Akaza N., Akamatsu H., Takeoka S., Mizutani H., Nakata S., Matsunaga K. Increased hydrophobicity in Malassezia species correlates with increased proinflammatory cytokine expression in human keratinocytes. Med Mycol. 2012;50(8):802-10.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Song YC, Hahn HJ, Kim JY, Ko JH, Lee YW, Choe YB, Ahn KJ. Epidemiologic study of Malassezia yeasts in acne patients by analysis of 26S rDNA PCR-RFLP. Ann Dermatol. 2011;23(3):321-8. doi:10.5021/ad.2011.23.3.321.</mixed-citation><mixed-citation xml:lang="ru">Song Y.C., Hahn H.J., Kim J.Y., Ko J.H., Lee Y.W., Choe Y.B., Ahn K.J. Epidemiologic study of Malassezia yeasts in acne patients by analysis of 26S rDNA PCR-RFLP. Ann Dermatol. 2011;23(3):321-8. doi: 10.5021/ad.2011.23.3.321</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Bek-Thomsen M, Lomholt HB, Kilian M. Acne is not associated with yet-uncultured bacteria. J Clin Microbiol. 2008;46(10):3355-60.</mixed-citation><mixed-citation xml:lang="ru">Bek-Thomsen M., Lomholt H.B., Kilian M. Acne is not associated with yet-uncultured bacteria. J Clin Microbiol. 2008;46(10):3355-60.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Brook I, Frazier EH, Cox ME, Yeager JK. The aerobic and anaerobic microbiology of pustular acne lesions. Anaerobe. 1995;1(6):305-7.</mixed-citation><mixed-citation xml:lang="ru">Brook I., Frazier E.H., Cox M.E., Yeager J.K. The aerobic and anaerobic microbiology of pustular acne lesions. Anaerobe. 1995;1(6):305-7.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Samtsov AV, Araviyskaya ER. Federal clinical guidelines for the management of patients with acne. Moscow: Russian Society of Dermatovenereologists and Cosmetologists; 2013. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Самцов А.В., Аравийская Е.Р. Федеральные клинические рекомендации по ведению больных акне. М.: Российское общество дерматовенерологов и косметологов; 2013.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Hayashi N, Kurokawa I, Siakpere O, Endo A, Hatanaka T, Yamada M, Kawashima M. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. J Dermatol. 2018;45(8):951-62. doi: 10.1111/1346-8138.14497</mixed-citation><mixed-citation xml:lang="ru">Hayashi N., Kurokawa I., Siakpere O., Endo A., Hatanaka T., Yamada M., Kawashima M. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. J Dermatol. 2018;45(8):951-62. doi: 10.1111/1346-8138.14497</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Snarskaya ES. Antibacterial therapy of acne vulgaris. Vestnik Dermatologii i Venerologii. 2019;95(5):58-67. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Снарская Е.С. Антибактериальная терапия вульгарных акне // Вестник дерматологии и венерологии. 2019;95(5):58-67.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Eady EA, Cove JH, Holland KT, Cunliffe WJ. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol. 1990;122(2):233-44.</mixed-citation><mixed-citation xml:lang="ru">Eady E.A., Cove J.H., Holland K.T., Cunliffe W.J. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol. 1990;122(2):233-44.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Arzumanyan VG, Masyukova SA, Sergeev AYu, Grebenyuk DV, Ilina IV, Alieva ZA, et al. Sertaconazole and new possibilities of therapy in dermatology. Immunopathology, allergology, infektology. 2016;(4):80-4. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Арзуманян В.Г., Масюкова С.А., Сергеев А.Ю., Гребенюк Д.В., Ильина И.В., Алиева З.А. и др. Сертаконазол и новые возможности терапии в дерматологии // Иммунопатология, аллергология, инфектология. 2016;(4):80-4.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Borovaya A, Olisova O, Ruzicka T, Sardy M. Does isotretinoin therapy of acne cure or cause depression? Int J Dermatol. 2013;52(9):1040-52. doi: 10.1111/ijd.12169</mixed-citation><mixed-citation xml:lang="ru">Borovaya A., Olisova O., Ruzicka T., Sardy M. Does isotretinoin therapy of acne cure or cause depression? Int J Dermatol. 2013;52(9):1040-52. doi: 10.1111/ijd.12169</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Olisova OYu. Effectiveness of systemic retinoids for acne. Russian Medical Journal. 2016;(1):602-6. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Олисова О.Ю. Эффективность системных ретиноидов при акне // Русский медицинский журнал. 2016;(10):602-6.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Olisova OYu, Ma Ziyuan. Effectivness vs ineffectiveness of systemic retinoids in acne. Effective pharmacotherapy. 2020;16(9):18-22. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Олисова О.Ю., Ма Цзыюань. Эффективность vs неэффективность системных ретиноидов при акне // Эффективная фармакотерапия. 2020;16(9):18-22.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Lvov AN, Khaldin AA. Experience with the combined gel Isotrexin used in topical therapy for different forms of acne. Russian Journal of Skin and Venereal Diseases. 2008;10(5):83-5. (in Russian)</mixed-citation><mixed-citation xml:lang="ru">Львов А.Н., Халдин А.А. Опыт применения комбинированного геля Изотрексин в наружной терапии различных форм угревой болезни // Российский журнал кожных и венерических болезней. 2008;10(5):83-5.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">McCoy WH, Otchere E, Rosa BA, Martin J, Mann CM, Mitreva M. Skin ecology during sebaceous drought-how skin microbes respond to isotretinoin. J Investig Dermatol. 2019;139(3):732-5.</mixed-citation><mixed-citation xml:lang="ru">McCoy W.H., Otchere E., Rosa B.A., Martin J., Mann C.M., Mitreva M. Skin ecology during sebaceous drought-how skin microbes respond to isotretinoin. J Investig Dermatol. 2019;139(3):732-5.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
